User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Published

Journal Article

Research has demonstrated that certain vaginal gel products--microbicides containing antiretroviral drugs--may reduce HIV infection risk among women. But for vaginal gels to avert HIV and other sexually transmitted infections (STIs), at-risk women must be willing to use them as directed. These products must therefore be "acceptable" to women and an important component of acceptability is users' perception that the product will work to prevent infection. We sought to understand how women's perceptions of vaginal gel properties may shape their understanding of product efficacy for HIV and STI prevention. Sixteen women completed two in-depth qualitative interviews (k = 32) to identify the range and types of sensory perceptions they experienced when using two vaginal gels. We identified emergent themes and linkages between users' sensory perceptions and their beliefs about product efficacy. Users' predictions about product efficacy for preventing infection corresponded to measurable physical properties, including gel volume, location in the vagina, coating behavior, sensation of the gel in the vagina, leakage, and gel changes during coital acts. Although the women described similar sensory experiences (e.g., gel leaked from the vagina), they interpreted these experiences to have varying implications for product efficacy (e.g., leakage was predicted to increase or decrease efficacy). To improve microbicide acceptability, gel developers should investigate and deliberately incorporate properties that influence users' perceptions of efficacy. When a microbicide is approved for use, providers should educate users to anticipate and understand their sensory experiences; improving users' experience can maximize adherence and product effectiveness.

Full Text

Duke Authors

Cited Authors

  • Morrow, KM; Underhill, K; van den Berg, JJ; Vargas, S; Rosen, RK; Katz, DF

Published Date

  • October 2014

Published In

Volume / Issue

  • 43 / 7

Start / End Page

  • 1459 - 1467

PubMed ID

  • 24452632

Pubmed Central ID

  • 24452632

Electronic International Standard Serial Number (EISSN)

  • 1573-2800

International Standard Serial Number (ISSN)

  • 0004-0002

Digital Object Identifier (DOI)

  • 10.1007/s10508-013-0235-5

Language

  • eng